287 related articles for article (PubMed ID: 9626145)
21. Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men.
Pavlov EP; Harman SM; Chrousos GP; Loriaux DL; Blackman MR
J Clin Endocrinol Metab; 1986 Apr; 62(4):767-72. PubMed ID: 3005357
[TBL] [Abstract][Full Text] [Related]
22. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.
Bernardi F; Lanzone A; Cento RM; Spada RS; Pezzani I; Genazzani AD; Luisi S; Luisi M; Petraglia F; Genazzani AR
Eur J Endocrinol; 2000 May; 142(5):466-71. PubMed ID: 10802523
[TBL] [Abstract][Full Text] [Related]
23. [Correlation between neurotransmitters and neurosteroids and premenstrual syndrome patients of Gan-yang ascending syndrome and Gan-qi stagnation syndrome].
Gao H; Xia T; Qiao MQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1503-7. PubMed ID: 23359974
[TBL] [Abstract][Full Text] [Related]
24. DHEA, important source of sex steroids in men and even more in women.
Labrie F
Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
[TBL] [Abstract][Full Text] [Related]
25. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
de Kretser DM; Burger HG; Dumpys R
J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
[TBL] [Abstract][Full Text] [Related]
26. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women.
Holdstock L; Penland SN; Morrow AL; de Wit H
Psychopharmacology (Berl); 2006 Jun; 186(3):442-50. PubMed ID: 16240164
[TBL] [Abstract][Full Text] [Related]
27. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB
Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
[TBL] [Abstract][Full Text] [Related]
28. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.
Schmidt PJ; Purdy RH; Moore PH; Paul SM; Rubinow DR
J Clin Endocrinol Metab; 1994 Nov; 79(5):1256-60. PubMed ID: 7962316
[TBL] [Abstract][Full Text] [Related]
29. Impaired reduction of enhanced levels of dehydroepiandrosterone by oral dexamethasone in anorexia nervosa.
Monteleone P; Luisi M; Martiadis V; Serritella C; Longobardi N; Casarosa E; Genazzani AR; Maj M
Psychoneuroendocrinology; 2006 May; 31(4):537-42. PubMed ID: 16229957
[TBL] [Abstract][Full Text] [Related]
30. Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development.
Fadalti M; Petraglia F; Luisi S; Bernardi F; Casarosa E; Ferrari E; Luisi M; Saggese G; Genazzani AR; Bernasconi S
Pediatr Res; 1999 Sep; 46(3):323-7. PubMed ID: 10473049
[TBL] [Abstract][Full Text] [Related]
31. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
32. Plasma 16 beta-hydroxydehydroepiandrosterone in normal and pathological conditions in man.
Sekihara H; Sennett JA; Liddle GW; McKenna TJ; Yarbro LR
J Clin Endocrinol Metab; 1976 Nov; 43(5):1078-84. PubMed ID: 186475
[TBL] [Abstract][Full Text] [Related]
33. High levels of serum allopregnanolone in women with premature ovarian failure.
Bernardi F; Hartmann B; Casarosa E; Luisi S; Stomati M; Fadalti M; Florio P; Santuz M; Luisi M; Petraglia F; Genazzani AR
Gynecol Endocrinol; 1998 Oct; 12(5):339-45. PubMed ID: 9859027
[TBL] [Abstract][Full Text] [Related]
34. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
[TBL] [Abstract][Full Text] [Related]
35. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
36. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
37. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function.
Escobar-Morreale HF; Serrano-Gotarredona J; Avila S; Villar-Palasí J; Varela C; Sancho J
J Clin Endocrinol Metab; 1998 Jul; 83(7):2580-4. PubMed ID: 9661648
[TBL] [Abstract][Full Text] [Related]
38. Allopregnanolone, a GABAA receptor agonist, decreases gonadotropin levels in women. A preliminary study.
Timby E; Hedström H; Bäckström T; Sundström-Poromaa I; Nyberg S; Bixo M
Gynecol Endocrinol; 2011 Dec; 27(12):1087-93. PubMed ID: 21190418
[TBL] [Abstract][Full Text] [Related]
39. Allopregnanolone and mood disorders.
Bäckström T; Bixo M; Johansson M; Nyberg S; Ossewaarde L; Ragagnin G; Savic I; Strömberg J; Timby E; van Broekhoven F; van Wingen G
Prog Neurobiol; 2014 Feb; 113():88-94. PubMed ID: 23978486
[TBL] [Abstract][Full Text] [Related]
40. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
Pluchino N; Ninni F; Stomati M; Freschi L; Casarosa E; Valentino V; Luisi S; Genazzani AD; Potì E; Genazzani AR
Maturitas; 2008 Apr; 59(4):293-303. PubMed ID: 18394829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
